LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 6 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 3. - Dataset (ID:20314)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 12.50 | 56.33 | 454 | 510 | 0.8926 | 0.4422 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.20 | 56.33 | 468 | 634 | 0.7405 | 0.4137 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 15.90 | 56.33 | 478 | 726 | 0.6620 | 0.4041 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 17.60 | 56.33 | 485 | 868 | 0.5603 | 0.3894 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 19.30 | 56.33 | 491 | 1090 | 0.4615 | 0.3762 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 21.00 | 56.33 | 495 | 1286 | 0.3927 | 0.3555 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.80 | 56.33 | 500 | 1460 | 0.3474 | 0.3475 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.50 | 56.33 | 502 | 1615 | 0.3144 | 0.3464 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 26.20 | 56.33 | 508 | 1764 | 0.2906 | 0.3475 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.90 | 56.33 | 514 | 1907 | 0.2726 | 0.3503 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.60 | 56.33 | 525 | 2050 | 0.2588 | 0.3569 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 31.30 | 56.33 | 526 | 2241 | 0.2371 | 0.3386 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 33.00 | 56.33 | 542 | 2479 | 0.2211 | 0.3449 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 34.70 | 56.33 | 554 | 2720 | 0.2056 | 0.3402 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 36.40 | 56.33 | 560 | 2958 | 0.1910 | 0.3368 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 38.10 | 56.33 | 572 | 3168 | 0.1820 | 0.3360 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 39.80 | 56.33 | 577 | 3393 | 0.1712 | 0.3395 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 41.50 | 56.33 | 578 | 3667 | 0.1588 | 0.3229 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 43.20 | 56.33 | 586 | 3942 | 0.1496 | 0.3278 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 44.90 | 56.33 | 605 | 4212 | 0.1442 | 0.3376 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 46.60 | 56.33 | 616 | 4538 | 0.1366 | 0.3366 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 48.30 | 56.33 | 619 | 4875 | 0.1277 | 0.3294 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 50.00 | 56.33 | 635 | 5234 | 0.1218 | 0.3358 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 51.70 | 56.33 | 643 | 5553 | 0.1162 | 0.3371 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 53.40 | 56.33 | 671 | 5809 | 0.1160 | 0.3511 |